Passionately committed to applying our leadership in cellular metabolism to transform the lives of people with genetically defined diseases
Location: United States, Massachusetts, Cambridge
Employees: 201-500
Total raised: $184M
Founded date: 2008
Investors 1
Date | Name | Website |
17.07.2021 | ARCH Ventu... | archventur... |
Funding Rounds 2
Date | Series | Amount | Investors |
24.07.2013 | IPO | $106M | - |
17.11.2011 | Series C | $78M | - |
Mentions in press and media 23
Date | Title | Description | Source |
05.03.2024 | Agios to Present at the Leerink Partners Global Biopharma Co... | - | globenewsw... |
27.10.2022 | Agios sells cancer drug royalty, raising $132M to fund rare ... | Agios Pharmaceuticals’ pivot from cancer to rare diseases culminated in the $1.8 billion sale of its... | medcitynew... |
04.11.2021 | CENTOGENE Expands Partnership With Agios to Generate Novel I... | CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases Providi... | marketscre... |
13.08.2020 | Mission Bio Lands $70M to Expand Cancer Therapies With Singl... | What You Should Know: – Mission Bio raises $70 million in Series C funding led by Novo Growth to acc... | hitconsult... |
30.09.2019 | Agios drug improves progression-free survival in Phase III c... | A drug used to treat a form of adult leukemia has shown efficacy in a form of bile duct cancer that ... | medcitynew... |
14.09.2016 | Agios sets out to raise $150M; AC Immune IPO sets valuat... | In biotech, you raise money when you can. And just days after Agios $AGIO spelled out plans for a ... | endpts.com... |
26.03.2015 | Flagship Ventures raises $537M in new fund; plans to launch ... | The company’s previous fund was $269 million. Some of its more successful exits during this biotech ... | medcitynew... |
12.12.2014 | Cornerstone’s cancer metabolism drugs sap tumor cells’ energ... | The 15-year-old New Jersey company is now aiming to raise its profile in the wake of competitor Agio... | medcitynew... |
28.08.2013 | 11 health companies make the World Economic Group tech pione... | Nearly one-third of the 36 emerging technology pioneers chosen by the World Economic Forum this year... | medcitynew... |
24.07.2013 | UPDATED: Agios Pharma launches oversized $106M IPO | Agios Pharmaceuticals has begun an anticipated busy week of biotech IPOs, pricing more than 5.8 mill... | fiercebiot... |
Show more